+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030- Product Image
Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030- Product Image
Sale

Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887515
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hemostasis diagnostics market is evolving rapidly, shaped by innovation in clinical laboratory technologies and rising demands for precise, patient-centered care. Industry leaders face new challenges and opportunities as testing platforms and regulatory frameworks advance in tandem across global regions.

Market Snapshot: Hemostasis Diagnostics

The Hemostasis Diagnostics Market grew from USD 620.10 million in 2024 to USD 672.05 million in 2025. It is expected to continue growing at a CAGR of 8.22%, reaching USD 996.60 million by 2030.

Scope & Segmentation of the Hemostasis Diagnostics Market

  • Product Types: Instruments and analyzers, including automated and point-of-care devices. Reagents and kits, covering consumables and ready-to-use formulations. Software and services, incorporating laboratory information systems, maintenance, calibration, preventive maintenance, and training.
  • Technology Types: Chromogenic assays (e.g., factor VIII, factor X, thrombin inhibition), Clotting assays (e.g., activated partial thromboplastin time, fibrinogen, prothrombin, thrombin time), Immunologic assays (e.g., antiphospholipid antibodies, D-dimer, protein C and S), Molecular assays (e.g., genotyping and PCR-based tests).
  • End Users: Diagnostic laboratories (hospital-based, independent labs), Hospitals and clinics (secondary and tertiary care), Research institutes (academic).
  • Applications: Disease diagnosis (bleeding disorders, disseminated intravascular coagulation, thrombophilia), Screening and prevention (population and prenatal), Treatment monitoring (anticoagulant therapy monitoring, DOAC, heparin, warfarin).
  • Regions: Americas (with country data for United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Sysmex Corporation, Instrumentation Laboratory Company, Thermo Fisher Scientific Inc., Diagnostica Stago SAS, Ortho Clinical Diagnostics Holdings LLC, bioMérieux SA.

Key Takeaways for Senior Decision-Makers

  • Technological advancements in automated systems and digital integration are driving the shift to patient-centric diagnostic workflows and remote service models.
  • Stakeholders are prioritizing validated platforms that enable standardization, interoperability, and performance consistency across diverse clinical environments.
  • The ongoing evolution of assay technologies supports personalized medicine initiatives, particularly in genotyping and precise monitoring of direct oral anticoagulants.
  • Cost containment is influencing procurement patterns, with a notable pivot toward reagent efficiency, consumable reduction, and adaptive pricing models such as reagent rental and subscription services.
  • Regional market growth is being led by infrastructure investments and innovative partnerships, notably in Asia-Pacific and high-volume laboratories in North America.
  • Flexible solutions meeting the varied needs of end users—from rapid point-of-care assessments to advanced research capabilities—are becoming essential for market penetration.

Impact of U.S. Tariff Policies on Supply Chains

The introduction of new tariffs in the United States in 2025 is expected to influence product import costs for both instruments and reagents within hemostasis diagnostics. Manufacturers and distributors are revisiting sourcing strategies, exploring regional production and tariff-free options to safeguard pricing and supply chain continuity. Laboratories are deploying scenario planning and demand forecasting to address possible price fluctuations and maintain operational stability in a more complex procurement landscape.

Methodology & Data Sources

This report synthesizes insights from primary interviews with experienced clinicians and laboratory directors, complemented by thorough secondary research into regulatory dynamics, product pipelines, and global supply chain influences. Data integrity is ensured through transparent sourcing and systematic cross-verification of qualitative and quantitative evidence.

Why This Report Matters

  • Offers a comprehensive view of trends, segmentation, and regulatory drivers critical for informed strategic planning.
  • Enables benchmarking of competitors and identification of high-potential opportunities by geography, product innovation, and clinical application.
  • Equips leadership teams with scenario-based recommendations to adapt procurement, optimize operations, and accelerate innovation response in a dynamic regulatory and economic context.

Conclusion

The hemostasis diagnostics market stands at a pivotal intersection of clinical innovation, digital integration, and regulatory evolution. Stakeholders equipped with clear, data-driven intelligence can confidently drive growth and resilience amid shifting global dynamics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hemostasis Diagnostics Market, by Product
8.1. Introduction
8.2. Instruments and Analyzers
8.2.1. Automated Analyzers
8.2.2. Point of Care Instruments
8.3. Reagents and Kits
8.3.1. Consumables
8.3.2. Ready to Use Kits
8.4. Software and Services
8.4.1. Laboratory Information Systems
8.4.2. Maintenance and Support Services
8.4.2.1. Calibration
8.4.2.2. Preventive Maintenance
8.4.2.3. Training
9. Hemostasis Diagnostics Market, by Technology
9.1. Introduction
9.2. Chromogenic Assay
9.2.1. Factor VIII Assay
9.2.2. Factor X Assay
9.2.3. Thrombin Inhibition Assay
9.3. Clotting Assay
9.3.1. Activated Partial Thromboplastin Time
9.3.2. Fibrinogen Assay
9.3.3. Prothrombin Time
9.3.4. Thrombin Time
9.4. Immunologic Assay
9.4.1. Antiphospholipid Antibodies
9.4.2. D Dimer
9.4.3. Protein C S
9.5. Molecular Assay
9.5.1. Genotyping Tests
9.5.2. Pcr Based Tests
10. Hemostasis Diagnostics Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital Based Labs
10.2.2. Independent Labs
10.3. Hospitals and Clinics
10.3.1. Secondary Care Hospitals
10.3.2. Tertiary Care Hospitals
10.4. Research Institutes
10.4.1. Academic Research
11. Hemostasis Diagnostics Market, by Application
11.1. Introduction
11.2. Disease Diagnosis
11.2.1. Bleeding Disorders
11.2.2. D I C
11.2.3. Thrombophilia
11.3. Screening and Prevention
11.3.1. Population Screening
11.3.2. Prenatal Screening
11.4. Treatment Monitoring
11.4.1. Anticoagulant Therapy Monitoring
11.4.2. Doac
11.4.3. Heparin
11.4.4. Warfarin
12. Americas Hemostasis Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Hemostasis Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Hemostasis Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Siemens Healthineers AG
15.3.2. F. Hoffmann-La Roche AG
15.3.3. Danaher Corporation
15.3.4. Abbott Laboratories
15.3.5. Sysmex Corporation
15.3.6. Instrumentation Laboratory Company
15.3.7. Thermo Fisher Scientific Inc.
15.3.8. Diagnostica Stago SAS
15.3.9. Ortho Clinical Diagnostics Holdings, LLC
15.3.10. bioMérieux SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HEMOSTASIS DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. HEMOSTASIS DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. HEMOSTASIS DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HEMOSTASIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HEMOSTASIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HEMOSTASIS DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY READY TO USE KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CALIBRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PREVENTIVE MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TRAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR VIII ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR X ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN INHIBITION ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTEIN C S, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GENOTYPING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PCR BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY BLEEDING DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D I C, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBOPHILIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTICOAGULANT THERAPY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DOAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY WARFARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 110. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 112. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 113. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 114. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 115. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 117. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 118. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 119. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 120. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 122. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 123. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 124. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 126. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 127. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 128. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 137. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 138. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 145. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 219. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 224. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 226. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 227. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 228. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 229. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 231. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 232. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 233. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 235. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 236. GERMANY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 237. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 241. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 242. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 244. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 245. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 246. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 247. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 249. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 251. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 253. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 254. FRANCE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 273. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 275. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 276. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 277. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 278. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 280. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 281. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 282. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 283. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 285. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 286. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 287. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 289. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 290. ITALY HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 291. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 295. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 296. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2030 (USD MILLION)
TABLE 298. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2030 (USD MILLION)
TABLE 299. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2030 (USD MILLION)
TABLE 300. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2030 (USD MILLION)
TABLE 301. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 303. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 304. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 305. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 307. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2030 (USD MILLION)
TABLE 308. SPAIN HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. UNITED AR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hemostasis Diagnostics market report include:
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Abbott Laboratories
  • Sysmex Corporation
  • Instrumentation Laboratory Company
  • Thermo Fisher Scientific Inc.
  • Diagnostica Stago SAS
  • Ortho Clinical Diagnostics Holdings, LLC
  • bioMérieux SA

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 672.05 Million
Forecasted Market Value ( USD ) by 2030 $ 996.6 Million
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Coagulation & Hemostasis Testing Market by Product Type, Test Type, End User, Technology, Workflow - Global Forecast to 2030 - Product Image

Coagulation & Hemostasis Testing Market by Product Type, Test Type, End User, Technology, Workflow - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (POC Testing Systems, Consumables), By Test (Prothrombin Time Test, D Dimer Test), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (POC Testing Systems, Consumables), By Test (Prothrombin Time Test, D Dimer Test), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Hemostasis Diagnostics - Global Strategic Business Report - Product Image

Hemostasis Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Hemostasis Diagnostic Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Hemostasis Diagnostic Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 153 Pages
  • Global
From
Hemostasis Diagnostic Devices and Equipment Market Report 2025 - Product Image

Hemostasis Diagnostic Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Market

The Hemostasis Test market is a subset of the larger Coagulation and Hemostasis Testing market. Hemostasis Tests are used to measure the ability of the body to form clots and stop bleeding. These tests are used to diagnose and monitor a variety of conditions, including bleeding disorders, thrombosis, and other clotting-related diseases. Hemostasis Tests are typically performed in a laboratory setting, using a variety of methods, including manual and automated techniques. The Hemostasis Test market is highly competitive, with a number of companies offering a range of products and services. These include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, and Beckman Coulter. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.